Women across the UK are facing renewed challenges amid ongoing shortages of certain hormone replacement therapy (HRT) products, particularly two widely used patch brands, Estradot transdermal and FemSeven Conti. As these supply disruptions persist, healthcare professionals and advocacy groups are urging women to seek medical advice rather than resorting to self-medication, highlighting the anxiety and health risks that can arise when familiar treatments become unavailable.
Supply Chain Issues Disrupting Access to Key HRT Patches
The Department of Health has confirmed that manufacturing and distribution delays are behind the shortages of Estradot and FemSeven Conti patches, two staples in menopausal hormone therapy. These products deliver estrogen transdermally, a preferred method for many women due to its steady hormone release and reduced side effects compared to oral options.
Serious Shortage Protocols (SSPs) have been activated, allowing pharmacists to dispense alternative HRT products without requiring new prescriptions, provided patients consent. However, the transition is not always straightforward, as the substitutes may have different formulations or delivery systems that can affect efficacy and tolerability.
The Impact on Women’s Health and Wellbeing
For many women, finding the right HRT formula is a delicate process involving trial and error to balance symptom relief with manageable side effects. Pharmacists and GPs emphasize that switching brands or types of HRT without professional guidance can lead to unwanted reactions such as skin irritation or reduced symptom control.
Dr Ursula Mason, chair of the Royal College of General Practitioners Northern Ireland, notes that the disruption can trigger significant anxiety. “When a woman has found a preparation that works well for them, changing it can be distressing,” she explains. Patients are reassured that substitutions must contain the same active ingredient and dose, but individual responses can still vary.
Roisin Hillman, co-founder of Menopause Together, a menopause support charity in Northern Ireland, underscores the emotional toll these shortages impose. “Women are often frustrated because once they find an HRT that suits them, it frequently becomes unavailable,” she says. This uncertainty can impact mental health, as effective HRT plays a crucial role in managing mood swings, sleep disturbances, and other menopausal symptoms.
Guidance for Women Navigating HRT Shortages
Healthcare professionals stress the importance of consulting GPs or pharmacists rather than self-medicating or sharing medication. Paul Irvine, a Belfast-based pharmacy manager, highlights the risks of switching products without advice, noting that side effects or reduced effectiveness are common when women try unfamiliar brands on their own.
Women are encouraged to:
- Contact their GP or pharmacist promptly if their usual HRT is unavailable.
- Discuss symptom changes or side effects when trying alternative treatments.
- Avoid sharing HRT patches or medications with others, as individual prescriptions are tailored to specific needs.
- Request longer-term prescriptions where possible to mitigate the impact of future shortages.
Systemic Challenges Behind Persistent HRT Shortages
The current supply disruptions are part of a broader pattern of medication shortages affecting various drug classes across the UK and globally. Manufacturing bottlenecks, increased demand, and logistical hurdles have all contributed to patchy availability of HRT products.
Unlike some medications, HRT is highly personalized, and the market for specific brands can be limited, making it vulnerable to supply shocks. Additionally, the stigma and under-recognition of menopause in healthcare systems have historically limited investment and innovation in this field, contributing indirectly to supply issues.
Advocates argue that addressing these shortages requires a multi-pronged approach: improving manufacturing resilience, diversifying supply chains, and enhancing clinical support to help women manage transitions between therapies smoothly.
Looking Ahead: Supporting Women Through Menopause Amid Uncertainty
As shortages continue, the need for robust healthcare guidance and patient education is more critical than ever. The menopause is a natural phase affecting millions of women, yet many still face barriers to effective treatment, including medication access.
By fostering open dialogue between patients and healthcare providers, and by ensuring that alternatives are safely and thoughtfully prescribed, the healthcare system can mitigate some of the distress caused by these shortages. Meanwhile, ongoing advocacy work aims to raise awareness of menopause as a significant health issue deserving of dedicated resources and research.
For women experiencing menopause symptoms, the message is clear: do not delay seeking professional advice. While supply challenges persist, expert support remains available to help navigate treatment options and maintain quality of life during this transitional period.
Recommended reading
For more context, see related Peack News coverage and explainers linked below.